![Henry R. Costantino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henry R. Costantino
Keine laufenden Positionen mehr
Profil
Henry R.
Costantino is the founder of Group14.
Technologies, Inc. Prior to founding Group14.
Technologies, he worked as the Chief Scientific Officer-Delivery at MDRNA, Inc. from 2003 to 2010.
He holds a doctorate degree from the Massachusetts Institute of Technology and undergraduate and graduate degrees from The Johns Hopkins University.
Ehemalige bekannte Positionen von Henry R. Costantino
Unternehmen | Position | Ende |
---|---|---|
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Technik-/Wissenschafts-/F&E-Leiter | 22.07.2010 |
Group14 Technologies, Inc.
![]() Group14 Technologies, Inc. Electrical ProductsProducer Manufacturing Group14 Technologies, Inc. engages in the manufacture of engineered carbon materials. It offers silicon and silicon-carbon composite. The company was founded by Eric Luebbe, Henry Constantino, and Aaron Feaver in 2015 and is headquartered in Woodinville, WA. | Gründer | - |
Ausbildung von Henry R. Costantino
The Johns Hopkins University | Graduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
MDRNA, Inc.
![]() MDRNA, Inc. Miscellaneous Commercial ServicesCommercial Services MDRNA, Inc. engages in development and commercialization of innovative products based on proprietary molecular biology-based intranasal drug delivery technology. The company creates or utilizes novel formulation components or excipients that can transiently manipulate or open 'tight junctions' between cells in various tissues and thereby allow therapeutic drugs to reach the blood stream. The company is located in Hauppauge, NY. | Commercial Services |
Group14 Technologies, Inc.
![]() Group14 Technologies, Inc. Electrical ProductsProducer Manufacturing Group14 Technologies, Inc. engages in the manufacture of engineered carbon materials. It offers silicon and silicon-carbon composite. The company was founded by Eric Luebbe, Henry Constantino, and Aaron Feaver in 2015 and is headquartered in Woodinville, WA. | Producer Manufacturing |